These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 18848814)
1. Reactivation of hepatitis B virus in an inactive hepatitis B carrier with glucocorticoid pulse therapy. Tseng TC; Liu CJ; Hsieh SC; Chen PJ; Lai MY; Chen DS; Kao JH Dig Liver Dis; 2009 Apr; 41(4):322-3. PubMed ID: 18848814 [No Abstract] [Full Text] [Related]
2. Lack of correlation between hepatitis B surface antigen and hepatitis B virus DNA levels in blood donors. Allain JP; Sarkodie F; Candotti D; Opare-Sem O Transfusion; 2005 Jun; 45(6):1039-40. PubMed ID: 15935007 [No Abstract] [Full Text] [Related]
3. [Lamivudine treatment consensus from relative experts]. Lamivudine Clinical Practice Group Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):157-8. PubMed ID: 12108391 [No Abstract] [Full Text] [Related]
5. [Advance in clinical studies of the kinetics of hepatitis B virus]. Tang YT; Cao Q; Zhang DZ Zhonghua Gan Zang Bing Za Zhi; 2010 Jan; 18(1):75-7. PubMed ID: 20128981 [No Abstract] [Full Text] [Related]
6. American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy. Reddy KR; Beavers KL; Hammond SP; Lim JK; Falck-Ytter YT; Gastroenterology; 2015 Jan; 148(1):215-9; quiz e16-7. PubMed ID: 25447850 [No Abstract] [Full Text] [Related]
7. Viral load in hepatitis B e antigen-negative carriers with normal aminotransferase level. Liaw YF Hepatology; 2007 Sep; 46(3):947; author reply 947-9. PubMed ID: 17705263 [No Abstract] [Full Text] [Related]
8. American Gastroenterological Association Institute technical review on prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy. Perrillo RP; Gish R; Falck-Ytter YT Gastroenterology; 2015 Jan; 148(1):221-244.e3. PubMed ID: 25447852 [No Abstract] [Full Text] [Related]
9. [Spontaneous reactivation of the hepatitis B virus?]. Ciutică I; Bacq Y; Choutet P; Bastides F; Barin F; Gorgan V; Carstina D; Bocşan IS Bacteriol Virusol Parazitol Epidemiol; 1996; 41(3-4):131-4. PubMed ID: 9116400 [TBL] [Abstract][Full Text] [Related]
10. Monitoring of HBe antigen and alanine aminotransferase levels in hepatitis B virus DNA positive patients. Imtiaz F; Abbas Z; Moatter T J Coll Physicians Surg Pak; 2005 Feb; 15(2):103-4. PubMed ID: 15730837 [No Abstract] [Full Text] [Related]
11. [Relationship between clinics and the level of blood HBV DNA in different clinical types of hepatitis B]. Liu B; Xi Z Zhonghua Gan Zang Bing Za Zhi; 2002 Feb; 10(1):65-6. PubMed ID: 11856510 [No Abstract] [Full Text] [Related]
12. Hepatitis B surface antigen seroreversion in a T-cell lymphoma patient. Chen HW; Lin SA; Lin HC; Kao WY J BUON; 2011; 16(2):374-6. PubMed ID: 21766517 [No Abstract] [Full Text] [Related]
13. Fatal reactivation of hepatitis B virus in a patient who was hepatitis B surface antigen negative and core antibody positive before receiving chemotherapy for non-Hodgkin lymphoma. Wu JM; Huang YH; Lee PC; Lin HC; Lee SD J Clin Gastroenterol; 2009; 43(5):496-8. PubMed ID: 19247200 [TBL] [Abstract][Full Text] [Related]
14. [Reactivation of hepatitis B infection due to glucocorticoids]. Ramsoekh D; Metselaar HJ; de Man RA Ned Tijdschr Geneeskd; 2011; 155(50):A3710. PubMed ID: 22186363 [TBL] [Abstract][Full Text] [Related]
15. Immunoprophylaxis for hepatitis B virus reinfection after liver transplantation. Jeng LB; Lee WC; Yeh DS; Wang CC; Wang KL; Chen SC; Chen MF; Chien RN; Chiu CT; Lin DY Transplant Proc; 1994 Aug; 26(4):2243-4. PubMed ID: 8066736 [No Abstract] [Full Text] [Related]
16. Hepatitis B. Mohamadnejad M; Malekzadeh R N Engl J Med; 2004 Jun; 350(26):2719-20. PubMed ID: 15218580 [No Abstract] [Full Text] [Related]
17. Interaction between HIV and hepatitis B. Bonacini M AIDS; 1997 Nov; 11(14):1789-90. PubMed ID: 9386822 [No Abstract] [Full Text] [Related]
18. Risk of hepatitis B virus reactivation in patients with asthma or chronic obstructive pulmonary disease treated with corticosteroids. Kim TW; Kim MN; Kwon JW; Kim KM; Kim SH; Kim W; Park HW; Chang YS; Cho SH; Min KU; Kim YY Respirology; 2010 Oct; 15(7):1092-7. PubMed ID: 20630033 [TBL] [Abstract][Full Text] [Related]
19. Incidence and risk factors of progression to cirrhosis in inactive carriers of hepatitis B virus. Chu CM; Liaw YF Am J Gastroenterol; 2009 Jul; 104(7):1693-9. PubMed ID: 19455130 [TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus genotypes and hepatitis B surface antigen mutations in family contacts of hepatitis B virus infected patients with occult hepatitis B virus infection. Kumar GT; Kazim SN; Kumar M; Hissar S; Chauhan R; Basir SF; Sarin SK J Gastroenterol Hepatol; 2009 Apr; 24(4):588-98. PubMed ID: 19207682 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]